Global Coalition for Adaptive Research and Polaris Group Announce Commencement of ADI-PEG 20 in GBM

Polaris Now Enrolling in GBM AGILE, Registrational Phase 2-3 Adaptive Platform Trial for Patients with GlioblastomaPolaris lead biologic ADI-PEG 20 to be Evaluated Across Multiple International Trial SitesLARKSPUR, Calif.--(BUSINESS WIRE)--#GBMAGILE--Global Coalition for Adaptive Research (LARKSPUR, CA) and Polaris...

Related Keywords

Canada ,California ,United States ,Australia ,Howard Chen ,Gina Lee ,Rachel Rosenstein Sisson ,Nicholas Blondin ,Polaris Group ,National Brain Tumor Society ,Asian Fund For Cancer Research ,National Foundation For Cancer Research ,International Trial Sites ,Cure Brain Cancer Foundation ,Global Coalition For Adaptive Research ,Polaris Pharmaceuticals Inc ,Coalition For Adaptive Research ,Polaris Now Enrolling ,Registrational Phase ,Platform Trial ,Evaluated Across Multiple International Trial ,Global Coalition ,Adaptive Research ,Polaris Pharmaceuticals ,Macarena De La Fuente ,Associate Professor ,Miami Sylvester Comprehensive Cancer Center ,Assistant Professor ,Clinical Neurology ,Yale School ,Principal Investigators ,National Foundation ,Cancer Research ,Asian Fund ,